Sixty patients suffering from psoriasis of all clinical forms have been treated with an increased dosage of Bromocriptin. The age of the patients ranged from 20 to 72 years. Patients with contraindications for Bromocriptin were excluded from the test. In 80% a remission or reduction of psoriasis les
Treatment of psoriasis with Somatostatin
โ Scribed by G. Weber; G. Klughardt; M. Neidhardt; K. Galle; H. Frey; A. Geiger
- Publisher
- Springer-Verlag
- Year
- 1981
- Tongue
- English
- Weight
- 274 KB
- Volume
- 272
- Category
- Article
- ISSN
- 0340-3696
No coin nor oath required. For personal study only.
โฆ Synopsis
In 22 of 26 patients suffering from psoriasis the drip infusion therapy with Somatostatin, an inhibitor of the human growth hormone (HGH), leads to complete or partial remission of skin lesions. Fast reduction of joint pains in arthropathic psoriasis could be observed in four of four patients. The repeated measurement of HGH blood level showed a decrease of HGH in five cases following the Somatostatin therapy combined with the clinical remission.
๐ SIMILAR VOLUMES
## Abstract Three patients with external small bowel fistulas were successfully treated with bowel rest, total parenteral nutrition, and the somatostatin analog, octreotide. Two of the patients had received prior multimodality therapy, including radiation, for gynecologic cancer. The time intervals